COVID-19 vaccination in Singapore

Last updated

COVID-19 vaccination in Singapore
COVID-19 Vaccination Centre in Singapore 20220113 141437.jpg
A COVID-19 Vaccination Centre in Singapore
Date30 December 2020 (2020-12-30) – present
Location Singapore
Cause COVID-19 pandemic in Singapore
Participants10,818,023 total doses administered (as of 27 October 2021) [1] [a] [b]

The COVID-19 vaccination in Singapore is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Singapore has a very high vaccination rate, with more than 92% of its total population (and more than 93% of its eligible population) having completed their vaccination regimen. [2] [3]

Contents

Background

Total number of people vaccinated in Singapore under NVP as of 30 November 2024 [refresh]

  Unvaccinated population (7.0%)
  Population who are fully vaccinated [3] (92%)
  Population who have received only one dose of a two-dose vaccine [3] (1%)

The Singapore Government invested more than one billion Singapore dollars to sign advanced purchase agreements and made early down payments on promising vaccine candidates, such as Pfizer BioNTech, Moderna and CoronaVac. [4]

Expert Committee on COVID-19 Vaccination

On 5 October 2020, the Singapore Government appointed a 14-member Expert Committee on COVID-19 Vaccination, which was to advise and assess on the efficacy and safety of COVID-19 vaccines for use in Singapore. [5] On 24 December 2020, the Expert Committee submitted its recommendations on the overall vaccination strategy of Singapore to the government. [6] In its recommendations, they highlighted that two groups of people had to be prioritised for vaccination: people who are at high risk of infection, the frontline healthcare workers; and people who are vulnerable of severe diseases and complications from infections, the elderly. [6] The Committee continued to advise on the use of vaccines as the pandemic continues. It recommended booster shots for people above 60 of age as evidence of declining efficacy of vaccination over time emerged, [7] and updated recommendations for those with mild skin reactions after first dosage to continue their vaccination programme. [8]

2020

On 14 December 2020, Singapore became the first Asian country to approve Pfizer-BioNTech's coronavirus vaccine. [9] The first shipment of the vaccine arrived seven days later on 21 December. [10] [11]

Singapore also received its first shipment of Sinovac Biotech's CoronaVac vaccine, on 22 December 2020. However, the vaccine was not authorised for use by the Health Sciences Authority (HSA). [12] [13] On 2 June 2021, MOH approved the Sinovac vaccine for used in private healthcare settings so people, who are not suitable to take the mRNA vaccines, can take the Sinovac vaccine. However, since the China-made vaccine is not part of the national programme, those who choose to receive it will not be eligible for the Vaccine Injury Financial Assistance Programme (VIFAP) should they develop any adverse reactions. [14] [15] [16]

On 30 December 2020, Singapore became the first country in Asia to start its COVID-19 vaccination campaign. The vaccine is free for all Singaporeans and long-term residents. Health workers, other frontline workers and seniors were the first inoculated with the vaccine jointly developed by BioNTech and Pfizer. [17]

2021

On 3 February 2021, Singapore also became the first country in Asia to approve Moderna's COVID-19 vaccine, jointly developed by the National Institute of Allergy and Infectious Diseases (NIAID), the Biomedical Advanced Research and Development Authority (BARDA), and Moderna. [18]

On 18 May, the Health Ministry announced that those who register for COVID-19 vaccination from 19 May onwards will have their second dose scheduled six to eight weeks after the first, instead of three to four weeks later. [19] This change in strategy was aimed to have 400,000 more people in Singapore to be given at least one vaccine dose by end-July so that virtually all eligible Singapore residents will get at least one dose by early August. [20] [21] However, as vaccine supplies continue to arrive as planned and most of the population who are willing to take the vaccine will have received their first dose by the second half of July, MOH announced on 29 June that the interval between the first and second doses of the COVID-19 vaccine would revert to four weeks. This was part of the efforts to ensure that more of the population will be fully vaccinated earlier. [22] [23] On 9 July, it was announced that the interval between doses of the Pfizer-BioNTech vaccine would be further shortened to 3 weeks. [24] It was further added that those who had previously taken a vaccine not approved under the National Vaccination Programme would be advised to take 2 doses of the approved ones. [25]

The Health Sciences Authority (HSA) also approved the use of the Pfizer-BioNTech coronavirus vaccine for children aged 12 to 15; previously, it was given only to those aged 16 years and above. It was granted interim authorization by the HSA under the Pandemic Special Access Route in December 2020. [21] [26] [27]

On 24 June, the Health Ministry concluded a purchase agreement with Novavax for its non-mRNA COVID-19 vaccine, with shipments expected to arrive in Singapore before the end of 2021. [28]

On 28 July, IHH Healthcare Singapore obtained approval to import the Sinopharm BIBP vaccine (BBIBP-CorV) via the special access route (SAR). [29] The SAR was set up on 31 May to allow individuals to choose vaccines not under the national inoculation program. [30]

On 2 August, Senior Minister of State for Health Janil Puthucheary announced in Parliament that those who had allergic reactions after receiving the first dose of an mRNA COVID-19 vaccine will be invited to receive the Sinovac CoronaVac vaccine and will be deemed as fully vaccinated individuals. [31]

On 6 August, the Health Ministry announced it shall recognize all COVID-19 vaccines listed under the Emergency Use Listing (EUL) by the World Health Organization (WHO) starting from 10 August 2021. This means that Singapore recognizes all individuals that have been inoculated with a WHO-approved vaccine as fully vaccinated individuals and shall be accorded vaccination-differentiated safe management measures and travel concessions. [32]

On 20 September, an additional 101,000 doses of the Sinovac vaccine was delivered. [33]

On 23 October, the Health Sciences Authority (HSA) granted interim authorization under the Pandemic Special Access Route for the CoronaVac vaccine under a three-dose regime, following which it was included in the National Vaccination Programme. Those who are ineligible to take either of the approved mRNA vaccines would be invited for this vaccine and eligible for the Vaccine Injury Financial Assistance Programme (VIFAP). [34]

On 10 December, the Health Sciences Authority approved the use of the Pfizer-BioNTech coronavirus vaccine for children aged 5 to 11 with the first shots to be given by end-2021. At the same time, Pfizer-BioNTech coronavirus vaccine is approved for full registration. [35] [36] The first shipment of the paediatric vaccine arrived seven days later on 22 December with the first shots given on 27 December.

Booster shots

Singapore started the rolling out of booster shots for senior citizens above 60 years of age from 14 September 2021. [37] Subsequently, from 4 October, it will start giving booster shots for the eligible population above 50 years of age, followed by individuals above 30 years of age from 9 October. The eligible population should have their second dose taken before 6 months. [38] From 24 November, eligible population who completed their second dose before 5 months can get booster shots for all age groups. [39] [40] On 10 December, the use of booster shots is extended to individuals above 18 years of age starting from 14 December. [35] [36] From 14 March 2022, children aged 12 to 17 will need to get a booster shot within 270 days of receiving their second dose of the COVID-19 vaccine. [41] Those who do not take the booster shot after 9 months from the second dose will have their vaccination status removed.

2022

On 14 February 2022, the Health Sciences Authority (HSA) announced that it had granted interim authorization for the Novavax vaccine under the brand name Nuvaxovid, under the Pandemic Special Access Route; it is a two-dose regimen, and shall be included in the National Vaccination Programme for adults aged 18 years old and above. Presently, it is a protein-based subunit vaccine authorized in Singapore. [42] [43]

From May 2022, vaccination centres will be consolidated as Singapore transits to COVID-19 resilience. [44]

Recognition of vaccine certificates

On 19 August 2021, the Immigration and Checkpoints Authority (ICA) shall issue a tamper-proof vaccination sticker that is to be pasted onto their travel documents and can serve as proof of vaccination. The issuance of this special sticker will be limited to travelers who have been vaccinated with a COVID-19 vaccine under the Emergency Use Listing (EUL) by the World Health Organization (WHO) and the presentation of a valid English-language vaccination certificate. [45]

On 24 September 2021, Malaysian National Recovery Council chairman Muhyiddin Yassin confirmed that Malaysia and Singapore would recognise each other's vaccination certificates in order to facilitate travel between the two countries. [46]

Vaccines used

Vaccines delivered per pharmaceutical company as of 30 November 2024 [refresh][ citation needed ]

  Moderna (962,127) (22.65%)
  Pfizer-BioNTech (3,085,524) (72.64%)
  Sinovac (301,000) (4.71%)

National vaccination programme

VaccineProgressDoses orderedApprovalDeploymentManufacturerRef.
Pfizer–BioNTech/Comirnaty Approved for useunknownGreen check.svg 14 December 2020 (EUA)Green check.svg 30 December 2020 Flag of the United States.svg Flag of Germany.svg Pfizer and BioNTech -
Moderna Approved for useunknownGreen check.svg 3 February 2021 (EUA)Green check.svg 17 March 2021 Flag of the United States.svg Moderna -
CoronaVac Approved for use301,000Green check.svg 23 October 2021 (EUA)Green check.svg 4 June 2021 Flag of the People's Republic of China.svg Sinovac [34] [c]
Nuvaxovid Approved for useunknownGreen check.svg 14 February 2022 (EUA)Green check.svg 18 May 2022 Flag of the United States.svg Novavax [d] [47]

Special access route

VaccineProgressDoses orderedApprovalDeploymentManufacturerRef.
Sinopharm BIBP Partially approvedunknown Gold check mark.svg 28 July 2021 (EUA)Green check.svg 30 August 2021 Flag of the People's Republic of China.svg Sinopharm -
Johnson&Johnson/Janssen Partially approvedunknown Gold check mark.svg 10 August 2021 (EUA)Pending Flag of the United States.svg Flag of Belgium (civil).svg Flag of the Netherlands.svg Janssen -
Oxford–AstraZeneca/AZD1222/Covishield Partially approvedunknown Gold check mark.svg 10 August 2021 (EUA)Pending Flag of the United Kingdom.svg Flag of Sweden.svg University of Oxford and AstraZeneca [e]
Covaxin Partially approvedunknown Gold check mark.svg 3 November 2021 (EUA)Pending Flag of India.svg Bharat Biotech -
Convidecia Partially approvedunknown Gold check mark.svg 19 May 2022 (EUA)Pending Flag of the People's Republic of China.svg CanSino Biologics -

Notes

  1. ↑ 10,049,015 under the national vaccination programme, 4,734,669 of which have received at least the first dose, 4,675,888 have been fully vaccinated, and 760,408 have received their booster shots; 45,484 (25,079 individuals) under the WHO's emergency use list.
  2. ↑ From 29 October 2021, MOH will no longer report number of doses.
  3. ↑ The CoronaVac vaccine was previously issued emergency authorization under the Special Access Route on 2 June 2021 upon being listed under the Emergency Use Listing (EUL) by the World Health Organization (WHO).
  4. ↑ The Novavax COVID-19 vaccine under the brand names: Nuvaxovid and Covovax, the licensed vaccine of the vaccine manufactured by the Serum Institute of India was previously issued emergency authorization under the Special Access Route on 17 December 2021 upon being listed under the Emergency Use Listing (EUL) by the World Health Organization (WHO).
  5. ↑ This authorization includes Covishield, the licensed vaccine of the vaccine manufactured by the Serum Institute of India.

Related Research Articles

<span class="mw-page-title-main">CoronaVac</span> Vaccine against COVID-19

CoronaVac, also known as the Sinovac COVID-19 vaccine, was a whole inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech. It was phase III clinically trialled in Brazil, Chile, Indonesia, the Philippines, and Turkey and relies on traditional technology similar to other inactivated-virus COVID-19 vaccines, such as the Sinopharm BIBP vaccine, another Chinese vaccine, and Covaxin, an Indian vaccine. CoronaVac does not need to be frozen, and both the final product and the raw material for formulating CoronaVac can be transported refrigerated at 2–8 °C (36–46 °F), the temperatures at which flu vaccines are kept.

<span class="mw-page-title-main">Pfizer–BioNTech COVID-19 vaccine</span> Type of vaccine for humans

The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. It is authorized for use in humans to provide protection against COVID-19, caused by infection with the SARS-CoV-2 virus. The vaccine is given by intramuscular injection. It is composed of nucleoside-modified mRNA (modRNA) that encodes a mutated form of the full-length spike protein of SARS-CoV-2, which is encapsulated in lipid nanoparticles. Initial guidance recommended a two-dose regimen, given 21 days apart; this interval was subsequently extended to up to 42 days in the United States, and up to four months in Canada.

The COVID-19 vaccination program in the Philippines was a mass immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the pandemic in the country. The vaccination program was initiated by the Duterte administration on March 1, 2021, a day after the arrival of the country's first vaccine doses which were donated by the Chinese government.

<span class="mw-page-title-main">COVID-19 vaccination in Australia</span> Ongoing COVID-19 vaccine program in Australia

The general COVID-19 vaccination in Australia program began on 22 February 2021 in response to the COVID-19 pandemic, with the goal of vaccinating all willing people in Australia before 2022. Front-line workers and aged care staff and residents had priority for being inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen vaccine on 25 June and the Moderna vaccine on 9 August. Although approved for use, the Janssen vaccine was not included in the Australian vaccination program as of June 2021.

<span class="mw-page-title-main">COVID-19 vaccination in Canada</span> COVID-19 vaccination programme in Canada

COVID-19 vaccination in Canada is an ongoing, intergovernmental effort coordinated between the bodies responsible in the Government of Canada to acquire and distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic in Canada. Provinces have worked with local municipal governments, hospital systems, family doctors and independently owned pharmacies to aid in part, or in full with vaccination rollout. The vaccination effort in full is the largest such immunization effort in the nation's history. The vaccination effort began December 14, 2020, and is currently ongoing.

<span class="mw-page-title-main">COVID-19 vaccination in South Africa</span> Plan to immunize against COVID-19 in South Africa

COVID-19 vaccination in South Africa is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccination in the United States</span> Plan to immunize against COVID-19

The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, and mass vaccinations began four days later. The Moderna vaccine was granted emergency use authorization on December 17, 2020, and the Janssen vaccine was granted emergency use authorization on February 27, 2021. It was not until April 19, 2021, that all U.S. states had opened vaccine eligibility to residents aged 16 and over. On May 10, 2021, the FDA approved the Pfizer-BioNTech vaccine for adolescents aged 12 to 15. On August 23, 2021, the FDA granted full approval to the Pfizer–BioNTech vaccine for individuals aged 16 and over.

The COVID-19 vaccination program in Colombia is an ongoing effort of mass immunization put in place by the Colombian government in order to respond to the ongoing COVID-19 pandemic. The virus causing COVID-19 was confirmed to have reached Colombia on 6 March 2020. Colombia's preparation and readiness for a vaccine program allowed it to join the first group of countries who received vaccines through COVAX. The first vaccine in Colombia was given to a nurse on 17 February 2021.

<span class="mw-page-title-main">COVID-19 vaccination in New Zealand</span> Ongoing COVID-19 vaccine programme in New Zealand

COVID-19 vaccination in New Zealand began on 20 February 2021, and will continue throughout the pandemic with the goal of vaccinating all willing New Zealanders aged 5 or older. Those aged 5 to 11 require a parent, caregiver or legal guardian accompany them to their appointment and provide consent for them to be vaccinated. As of 1 September, anyone in New Zealand, regardless of their immigration status, is eligible to be vaccinated.

The COVID-19 vaccination campaign in Quebec was a provincial effort to distribute and administer vaccines against COVID-19.

<span class="mw-page-title-main">COVID-19 vaccination in South Korea</span> Plan to immunize against COVID-19

COVID-19 vaccination in South Korea is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccination in Indonesia</span> Plan to immunize against COVID-19

The COVID-19 vaccination in Indonesia is an ongoing mass immunization in response to the COVID-19 pandemic in Indonesia. On 13 January 2021, the program commenced when President Joko Widodo was vaccinated at the presidential palace. In terms of total doses given, Indonesia ranks third in Asia and fifth in the world.

COVID-19 vaccination in Iceland is an effort to immunize the adult population of Iceland due to the COVID-19 pandemic. As of July 2021, more than 260,000 individuals had received at least one dose of COVID-19 vaccine, which was over 78% of the country's population. On November 21, 2021, 90% of the target population had been fully vaccinated, while around 1 in 5 people had received a booster on top of that; by December 9, 2021, the share of the population having received a booster shot exceeded 50%. On December 13, 2021, the country began offering Pfizer vaccinations to children aged 5–11.

<span class="mw-page-title-main">COVID-19 vaccination in Taiwan</span> Plan to immunize against COVID-19

COVID-19 vaccination in Taiwan is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in response to the ongoing pandemic in the country.

<span class="mw-page-title-main">COVID-19 vaccination in Ukraine</span> Plan to immunize against COVID-19

The COVID-19 vaccination campaign in Ukraine is an ongoing mass immunization campaign for the COVID-19 pandemic in Ukraine.

The following is a timeline of the COVID-19 pandemic in Singapore in 2021.

<span class="mw-page-title-main">Responses to the COVID-19 pandemic in December 2021</span> Sequence of major events in a virus pandemic

This article documents the chronology of the response to the COVID-19 pandemic in December 2021, which originated in Wuhan, China in December 2019. Some developments may become known or fully understood only in retrospect. Reporting on this pandemic began in December 2019.

The following is a timeline of the COVID-19 pandemic in Singapore in 2022.

COVID-19 vaccination in Ontario began in December 2020, when the first doses of the Pfizer-BioNTech COVID-19 vaccine were administered. In February 2021, shipments for both the Pfizer and Moderna vaccines increased significantly. By May 2021, over 50 percent of Ontarians had received their first dose. By the beginning of 2022, over 80 percent of Ontarians had received their first dose.

References

  1. ↑ "Update on Local COVID-19 Situation (28 October)". www.moh.gov.sg. 28 October 2021. Archived from the original on 28 April 2022. Retrieved 10 November 2021.
  2. ↑ Welle (www.dw.com), Deutsche (29 August 2021). "Coronavirus digest: Singapore is now the most-vaccinated country | DW | 29.08.2021". DW.COM. Deutsche Welle. Archived from the original on 1 June 2022. Retrieved 6 November 2021.
  3. 1 2 3 "COVID-19 Vaccination". www.moh.gov.sg. Archived from the original on 21 December 2021. Retrieved 23 June 2022.
  4. ↑ "Securing Singapore's access to COVID-19 vaccines". www.gov.sg. Archived from the original on 3 December 2021. Retrieved 28 April 2021.
  5. ↑ hermesauto (12 November 2020). "Top experts in healthcare, science appointed to committee to make recommendations on Singapore's Covid-19 vaccination strategy". The Straits Times. Archived from the original on 27 November 2022. Retrieved 22 September 2021.
  6. 1 2 "COVID-19: Government accepts committee's recommendations on vaccine strategy, to begin vaccinating healthcare workers from Dec 30". CNA. Archived from the original on 27 August 2022. Retrieved 22 September 2021.
  7. ↑ "PM Lee receives COVID-19 vaccine booster shot". CNA. Archived from the original on 29 May 2022. Retrieved 22 September 2021.
  8. ↑ "Those with mild skin reactions after first COVID-19 jab now allowed to receive further doses: Expert committee". CNA. Archived from the original on 30 November 2022. Retrieved 22 September 2021.
  9. ↑ Daga, John Geddie, Anshuman (14 December 2020). "Singapore approves Pfizer's COVID-19 vaccine in Asia first". Reuters. Archived from the original on 4 June 2021. Retrieved 28 April 2021.{{cite news}}: CS1 maint: multiple names: authors list (link)
  10. ↑ Chew, Hui Min (21 December 2020). "First shipment of COVID-19 vaccines arrives in Singapore". CNA. Archived from the original on 15 July 2021. Retrieved 28 April 2021.
  11. ↑ "Singapore gets first batch of vaccines, says DHL". Bangkok Post. 21 December 2020. Archived from the original on 10 February 2023. Retrieved 28 April 2021.
  12. ↑ "Sinovac vaccine will be used only when HSA gives approval". The New Paper. 25 March 2021. Archived from the original on 3 December 2021. Retrieved 28 April 2021.
  13. ↑ "China's Sinovac vaccine arrives in Singapore, but not yet approved for use". www.businesstimes.com.sg. 24 February 2021. Archived from the original on 24 February 2021. Retrieved 28 April 2021.
  14. ↑ "Sinovac COVID-19 vaccine to be allowed in Singapore under special access route after WHO approval". CNA. Archived from the original on 22 June 2021. Retrieved 3 July 2021.
  15. ↑ Goh, Timothy (2 June 2021). "Sinovac vaccine will be given to individuals not eligible for MRNA vaccines". The Straits Times. Archived from the original on 2 July 2021. Retrieved 2 June 2021.
  16. ↑ "7 more clinics chosen to offer Sinovac vaccine: MOH". Yahoo! News . Archived from the original on 29 May 2022. Retrieved 3 July 2021.
  17. ↑ "Singapore begins COVID-19 vaccination campaign". www.aa.com.tr. Archived from the original on 4 June 2021. Retrieved 28 April 2021.
  18. ↑ "Singapore approves Moderna's COVID-19 vaccine in Asia first". Reuters. 3 February 2021. Archived from the original on 3 December 2021. Retrieved 28 April 2021.
  19. ↑ hermesauto (18 May 2021). "S'pore delays 2nd Covid-19 vaccine dose to 6-8 weeks later; those aged 40-44 can register for jabs from Wednesday". The Straits Times. Archived from the original on 3 December 2021. Retrieved 21 May 2021.
  20. ↑ Lin, Chen (18 May 2021). "Singapore seeks COVID-19 vaccination for all adults by August". Reuters. Archived from the original on 14 March 2023. Retrieved 21 May 2021.
  21. 1 2 Yong, Nicholas (18 May 2021). "COVID: Singapore vaccination extended to 12-15 age group, dosing interval now 6-8 weeks". Yahoo! News . Archived from the original on 3 December 2021. Retrieved 21 May 2021.
  22. ↑ "Singapore shortens interval between COVID-19 vaccine doses to 4 weeks". CNA. Archived from the original on 11 July 2021. Retrieved 3 July 2021.
  23. ↑ hermesauto (29 June 2021). "Second Covid-19 jab can now be booked 4 weeks after first dose, from 6-8 weeks previously". The Straits Times. Archived from the original on 27 November 2022. Retrieved 3 July 2021.
  24. ↑ Toh, Ting Wei (10 July 2021). "Those taking Pfizer-BioNTech Covid-19 vaccine can now get second dose in 3 weeks instead of 4". The Straits Times. Archived from the original on 10 July 2021. Retrieved 10 July 2021.
  25. ↑ "Frequently Asked Questions". www.vaccine.gov.sg. Archived from the original on 20 December 2022. Retrieved 24 September 2021.
  26. ↑ Ng, Abigail (18 May 2021). "Singapore approves Covid vaccine for children ages 12 to 15 as cases surge". CNBC. Archived from the original on 20 October 2021. Retrieved 21 May 2021.
  27. ↑ "Children aged 12 to 15 to receive Pfizer-BioNTech COVID-19 vaccine in Singapore". CNA. Archived from the original on 18 May 2021. Retrieved 21 May 2021.
  28. ↑ Chong, Clara (24 June 2021). "S'pore may get non-mRNA Novavax Covid-19 vaccine before year-end". The Straits Times. Archived from the original on 24 June 2021. Retrieved 24 June 2021.
  29. ↑ "Private clinics set to offer Sinopharm COVID-19 vaccine in Singapore under special access route". CNA. Archived from the original on 30 July 2021. Retrieved 28 July 2021.
  30. ↑ Hui Min, Chew (31 May 2021). "People who want alternative COVID-19 vaccines can get them under special access route". CNA. Archived from the original on 2 August 2021. Retrieved 2 August 2021.
  31. ↑ Baker, Jalelah Abu (2 August 2021). "People with allergic reactions to mRNA COVID-19 vaccines can take Sinovac shots, will be considered fully vaccinated". CNA. Archived from the original on 7 August 2021. Retrieved 7 August 2021.
  32. ↑ Baker, Jalelah Abu (6 August 2021). "Those who opt for Sinovac, other vaccines under WHO emergency list to be considered fully vaccinated". CNA. Archived from the original on 6 August 2021. Retrieved 6 August 2021.
  33. ↑ Gena Soh (20 September 2021). "101,000 doses of Sinovac Covid-19 vaccine have arrived, jabs available in a few days: Ong Ye Kung". The Straits Times. Archived from the original on 28 April 2022. Retrieved 22 September 2021.
  34. 1 2 Matthew Mohan (23 October 2021). "Sinovac COVID-19 vaccine to be included in Singapore's national vaccination programme". CNA. Archived from the original on 23 April 2022. Retrieved 23 October 2021.
  35. 1 2 Ganapathy, Kurt (11 December 2021). "Singapore approves Pfizer-BioNTech COVID-19 vaccine for children aged 5 to 11; first shots by end-2021". CNA. Archived from the original on 4 April 2022. Retrieved 11 December 2021.
  36. 1 2 Chia, Osmond (11 December 2021). "S'pore approves Pfizer Covid-19 jab for children aged 5 to 11; booster shots for 18- to 29-year-olds from Dec 14". The Straits Times. Archived from the original on 25 June 2022. Retrieved 11 December 2021.
  37. ↑ Lim, Min Zhang (10 September 2021). "Seniors to be invited to register for Covid-19 booster shots from Sept 14". The Straits Times. ISSN   0585-3923. Archived from the original on 1 May 2022. Retrieved 29 September 2021.
  38. ↑ Tan, Cheryl (24 September 2021). "Covid-19 vaccine booster shots for those aged 50 to 59 from Oct 4". The Straits Times. ISSN   0585-3923. Archived from the original on 19 January 2022. Retrieved 29 September 2021.
  39. ↑ Tan, Cheryl (20 November 2021). "People can get Covid-19 booster shots 5 months after second dose from Nov 24". The Straits Times. Archived from the original on 5 December 2022. Retrieved 20 November 2021.
  40. ↑ "COVID-19 booster jabs to be offered 5 months after second dose for all eligible age groups". Archived from the original on 29 November 2022. Retrieved 20 November 2021.
  41. ↑ "Children aged 12 to 17 must get COVID-19 booster within 270 days of 2nd dose to maintain fully vaccinated status". CNA. Archived from the original on 21 January 2022. Retrieved 22 January 2022.
  42. ↑ Clara Chong (14 February 2022). "Novavax Covid-19 vaccine approved for those aged 18 and above in Singapore". The Straits Times . Archived from the original on 9 March 2022. Retrieved 14 February 2022.
  43. ↑ Andres, Gabrielle (14 February 2022). "Novavax's Nuvaxovid COVID-19 vaccine granted interim authorisation in Singapore". CNA. Archived from the original on 11 March 2022. Retrieved 6 March 2022.
  44. ↑ "Further Easing of Community Measures". Ministry of Health. 22 April 2022. Archived from the original on 10 October 2022. Retrieved 24 April 2022.
  45. ↑ Lim, Janice (19 August 2021). "Covid-19: ICA to issue tamper-proof vaccination sticker to newly-arrived travellers immunized abroad". Today Online. Archived from the original on 19 August 2021. Retrieved 19 August 2021.
  46. ↑ Shah, Mohd Farhaan (24 September 2021). "Muhyiddin: Malaysia and Singapore to mutually recognise vaccination certs as part of move towards reopening border". The Star . Archived from the original on 24 September 2021. Retrieved 25 September 2021.
  47. ↑ "Start of Nuvaxovid Covid-19 Vaccination and Joint Testing Vaccination Centre Operations". www.moh.gov.sg. Archived from the original on 13 October 2022. Retrieved 18 May 2022.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.